422720 L-744,832 - CAS 1177806-11-9 - Calbiochem

422720
Wyświetl ceny i dostępność

Przegląd

Replacement Information

Tabela kluczowych gatunków

Empirical FormulaCAS #
C₂₆H₄₅N₃O₆S₂ · 2HCl 1177806-11-9

Ceny i dostępność

Numer katalogowy DostępnośćOpakowanie Ilość/opak. Cena netto Ilość
422720-5MG
Pobieram informacje o dostępności...
Niedostępny w magazynie PLNiedostępny w magazynie PL
Dostępny w magazynie 
Wycofano
Dostępna ograniczona ilość
Dostępność będzie potwierdzona
    Remaining : Will advise
      Remaining : Will advise
      Doradzimy
      Skontaktuj się z Zespołem Obsługi Klienta
      Contact Customer Service

      Butelka szklana 5 mg
      Pobieranie ceny...
      Nie udało się pobrać ceny
      Minimum Quantity needs to be mulitiple of
      Na zapytanie Więcej informacji
      Zapisano ()
       
      Poproś o podanie ceny netto
      Description
      OverviewA cell-permeable potent and selective thiol-containing peptidomimetic farnesyltransferase (FTase) inhibitor with anti-tumor properties. Rapidly blocks p70S6K activation and DNA synthesis and promotes apoptosis in transgenic mice. Induces p21 expression and cell cycle arrest in the G1 phase. Displays synergistic effect with paclitaxel and epothilones in inhibiting tumor growth. Also mimics many of the effects of Rapamycin (Cat. No. 553210) and may be effective against tumors that exhibit inappropriate activation of the mTOR/p70S6K pathway.
      Catalogue Number422720
      Brand Family Calbiochem®
      Synonyms(2S)-2-[[(2S)-2-[(2S,3S)-2-[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentyl]oxy]-1-oxo-3-phenylpropyl]amino]-4-(methylsulfonyl)-butanoic Acid 1-Methylethyl Ester, L-744,382
      References
      ReferencesLaw, B.K., et al. 2000. J. Biol. Chem. 275, 10796.
      Law, B.K., et al. 1999. J. Biol. Chem. 274, 4743.
      Barrington, R.E., et al. 1998. Mol. Cell. Biol. 18, 85.
      Moasser, M.M., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 1369.
      Sepp-Lorenzino, L., and Rosen, N. 1998. J. Biol. Chem. 273, 20243.
      Kohl, N.E., et al. 1995. Nat. Med. 1, 792.
      Sepp-Lorenzino, L., et al. 1995. Cancer Res. 55, 5302.
      Product Information
      CAS number1177806-11-9
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₂₆H₄₅N₃O₆S₂ · 2HCl
      Chemical formulaC₂₆H₄₅N₃O₆S₂ · 2HCl
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetFarnesyltransferase (FTase)
      Purity≥98% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      L-744,832 - CAS 1177806-11-9 - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      L-744,832 - CAS 1177806-11-9 - Calbiochem Certificates of Analysis

      TitleLot Number
      422720

      References

      Przegląd literatury
      Law, B.K., et al. 2000. J. Biol. Chem. 275, 10796.
      Law, B.K., et al. 1999. J. Biol. Chem. 274, 4743.
      Barrington, R.E., et al. 1998. Mol. Cell. Biol. 18, 85.
      Moasser, M.M., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 1369.
      Sepp-Lorenzino, L., and Rosen, N. 1998. J. Biol. Chem. 273, 20243.
      Kohl, N.E., et al. 1995. Nat. Med. 1, 792.
      Sepp-Lorenzino, L., et al. 1995. Cancer Res. 55, 5302.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-December-2018 JSW
      Synonyms(2S)-2-[[(2S)-2-[(2S,3S)-2-[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentyl]oxy]-1-oxo-3-phenylpropyl]amino]-4-(methylsulfonyl)-butanoic Acid 1-Methylethyl Ester, L-744,382
      DescriptionA potent, cell-permeable, and selective thiol-containing peptidomimetic farnesyltransferase (FTase) inhibitor that blocks p70s6k activation and DNA synthesis and promote apoptosis in transgenic mice. Induces p21 expression and arrests cell in the G1 phase of the cell cycle. Also shown to act synergistically with paclitaxel and epothilones in inhibiting tumor growth and arresting cells in metaphase. Also mimics a number of the effects exhibited by Rapamycin (Cat. No. 553210) and may be effective against tumors that exhibit inappropirate activation of the mTOR/p70s6k pathway in animal models.
      FormWhite solid
      CAS number1177806-11-9
      Chemical formulaC₂₆H₄₅N₃O₆S₂ · 2HCl
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityDMSO (25 mg/ml) or H₂O (15 mg/ml)
      Storage -20°C
      Hygroscopic
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesLaw, B.K., et al. 2000. J. Biol. Chem. 275, 10796.
      Law, B.K., et al. 1999. J. Biol. Chem. 274, 4743.
      Barrington, R.E., et al. 1998. Mol. Cell. Biol. 18, 85.
      Moasser, M.M., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 1369.
      Sepp-Lorenzino, L., and Rosen, N. 1998. J. Biol. Chem. 273, 20243.
      Kohl, N.E., et al. 1995. Nat. Med. 1, 792.
      Sepp-Lorenzino, L., et al. 1995. Cancer Res. 55, 5302.